Section 1 Expanding the tropical disease product priority review voucher program to encourage prevention and treatment of coccidioidomycosis
Section 524(a)(3) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360n(a)(3)) is amended—
by redesignating subparagraph (S) as subparagraph (T); and
by inserting after subparagraph (R) the following:
“(S) Coccidioidomycosis.”